Floy® precisely and fully automatically measures the volume of the brain areas in the MRI in comparison with age- and gender-specific norm cohorts in order to be able to diagnose neurodegenerative diseases such as forms of dementia at an early stage.
More information
Floy® detects and measures multiple sclerosis lesions in brain MRIs fully automatically, also in comparison with previous examinations, to support precise multiple sclerosis diagnostics.
More information
Floy® precisely and fully automatically measures the volume of organs, abdominal wall muscles and subcutaneous and visceral fat tissue in abdominal MRIs and CTs. This enables early detection of metabolic diseases and health risk factors.
Floy® detects, classifies and measures malignant changes in the lung in the CT thorax, also by comparing previous examinations, in order to identify signs of lung cancer at an early stage.
More information
Floy® detects and classifies malignant changes of the spine in MRI and CT to detect tumors at an early stage with high accuracy.
More information
Floy® detects and classifies malignant changes in breast tissue in planar mammography in order to identify signs of breast cancer early and precisely.